MXPA04003297A - Derivados novedosos de benzotiacina su preparacion y uso. - Google Patents

Derivados novedosos de benzotiacina su preparacion y uso.

Info

Publication number
MXPA04003297A
MXPA04003297A MXPA04003297A MXPA04003297A MXPA04003297A MX PA04003297 A MXPA04003297 A MX PA04003297A MX PA04003297 A MXPA04003297 A MX PA04003297A MX PA04003297 A MXPA04003297 A MX PA04003297A MX PA04003297 A MXPA04003297 A MX PA04003297A
Authority
MX
Mexico
Prior art keywords
preparation
benzothiazine derivatives
novel benzothiazine
novel
derivatives
Prior art date
Application number
MXPA04003297A
Other languages
English (en)
Spanish (es)
Inventor
Alex Haahr Gouliaev
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of MXPA04003297A publication Critical patent/MXPA04003297A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA04003297A 2001-10-10 2002-10-02 Derivados novedosos de benzotiacina su preparacion y uso. MXPA04003297A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101498 2001-10-10
PCT/DK2002/000654 WO2003031422A1 (en) 2001-10-10 2002-10-02 Novel benzothiazine derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
MXPA04003297A true MXPA04003297A (es) 2004-07-23

Family

ID=8160760

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003297A MXPA04003297A (es) 2001-10-10 2002-10-02 Derivados novedosos de benzotiacina su preparacion y uso.

Country Status (8)

Country Link
US (1) US7199118B2 (cg-RX-API-DMAC7.html)
EP (1) EP1436270A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005508352A (cg-RX-API-DMAC7.html)
CN (1) CN1275951C (cg-RX-API-DMAC7.html)
CA (1) CA2458388A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04003297A (cg-RX-API-DMAC7.html)
NZ (1) NZ531511A (cg-RX-API-DMAC7.html)
WO (1) WO2003031422A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3547859B2 (ja) * 1995-07-14 2004-07-28 愛知機械工業株式会社 2方向差動クラッチ
FR2856064B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933698A1 (fr) * 2008-07-09 2010-01-15 Servier Lab Nouveaux derives de benzothiadiazines cycloalkylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2955107B1 (fr) * 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2012020848A1 (en) * 2010-08-10 2012-02-16 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
TWI873185B (zh) 2019-09-16 2025-02-21 日商武田藥品工業股份有限公司 唑稠合之嗒-3(2h)-酮衍生物
CN111393385B (zh) * 2020-04-15 2022-01-18 华南理工大学 一种苯并噻嗪甲醛衍生物的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3113075A (en) * 1960-10-17 1963-12-03 Merck & Co Inc Heterocyclic compounds
DE1302858B (cg-RX-API-DMAC7.html) * 1962-09-21 1972-05-04
FR1552763A (cg-RX-API-DMAC7.html) * 1963-11-08 1969-01-10
FR3136M (fr) 1963-11-08 1965-02-15 Merck & Co Inc Nouveaux médicaments diurétiques.
RU2214405C2 (ru) 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
DE10004572A1 (de) 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
WO2003031422A1 (en) 2003-04-17
CN1275951C (zh) 2006-09-20
EP1436270A1 (en) 2004-07-14
US20040242571A1 (en) 2004-12-02
NZ531511A (en) 2006-01-27
CA2458388A1 (en) 2003-04-17
CN1564817A (zh) 2005-01-12
JP2005508352A (ja) 2005-03-31
US7199118B2 (en) 2007-04-03

Similar Documents

Publication Publication Date Title
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
GB0114286D0 (en) Nucleoside Derivatives
PT1263724E (pt) Novos compostos
IS6658A (is) Ný efnasambönd
NO20034230L (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
MY134568A (en) Cb2 receptor agonists
MY128924A (en) Novel compounds
AP2001002088A0 (en) 4,4-Biarylpiperidine derivatives with opiod receptor activity.
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
DE60001586D1 (de) Diphenyl-piperidin derivate
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
DE60221537D1 (de) Pteridinon-derivate als modulatoren der chemokinrezeptor-aktivität
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
DE60208694D1 (de) Piperidinylmorpholinylderivate als modulatoren der aktivität des chemokinrezeptors
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
ATE274515T1 (de) Pyrazolopyridinderivate
ATE329916T1 (de) Azaindolylpiperidinderivate als antihistaminika und antiallergika
SE0302755D0 (sv) Novel compounds
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders